Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) EBT Margin (2023 - 2025)

Bioharvest Sciences has reported EBT Margin over the past 3 years, most recently at 25.02% for Q4 2025.

  • For Q4 2025, EBT Margin rose 1549.0% year-over-year to 25.02%; the TTM value through Dec 2025 reached 32.05%, up 1919.0%, while the annual FY2025 figure was 32.05%, 1919.0% up from the prior year.
  • EBT Margin was 25.02% for Q4 2025 at Bioharvest Sciences, up from 27.02% in the prior quarter.
  • Across five years, EBT Margin topped out at 160.07% in Q4 2023 and bottomed at 123.15% in Q1 2024.
  • The 3-year median for EBT Margin is 27.02% (2025), against an average of 2.54%.
  • Year-over-year, EBT Margin tumbled -20057bps in 2024 and then skyrocketed 9389bps in 2025.
  • Over 3 years, EBT Margin stood at 160.07% in 2023, then tumbled by -125bps to 40.51% in 2024, then soared by 38bps to 25.02% in 2025.
  • The last three reported values for EBT Margin were 25.02% (Q4 2025), 27.02% (Q3 2025), and 47.46% (Q2 2025) per Business Quant data.